Produção Nacional
Revisado por pares
Combining the Pharmacophore Features of Coumarins and 1,4-Substituted 1,2,3-Triazoles to Design New Acetylcholinesterase Inhibitors: Fast and Easy Generation of 4-Methylcoumarins/1,2,3-triazoles Conjugates via Click Chemistry
2016; Brazilian Chemical Society; Linguagem: Inglês
10.5935/0103-5053.20160033
ISSN1678-4790
AutoresFernando Torres, Guilherme Arraché Gonçalves, Kenia L. Vanzolini, Aloir A. Merlo, Bruna Gauer, Maribete Holzschuh, Saulo Fernandes de Andrade, Maristela Cabral da Silva Piedade, Solange Cristina García, Ivone Carvalho, Gilsane Lino von Poser, Daniel Fábio Kawano, Vera Lucia Eifler‐Lima, Quézia B. Cass,
Tópico(s)Synthesis and biological activity
ResumoCoumarins are a large class of compounds that display a range of interesting biological properties, being considered privileged structures because of the ability of their 2H-chromen-2-one nuclei to bind to multiple pharmacological targets.We hypothesized that the linkage of a second pharmacophore nucleus to the 2H-chromen-2-one core, the 1,2,3-triazole moiety, would entail more selective and pharmacologically active coumarins.Therefore, we describe the synthesis of fourteen 4-methylcoumarins/1,4-substituted 1,2,3-triazole conjugates, which were predicted by in silico methods to inhibit acetylcholinesterase (AChE) and proved to be moderate in vitro inhibitors of this enzyme.Molecular docking simulations suggest that the most active of these compounds has a putative binding mode similar to donepezil, both occupying the peripheral anionic site of AChE, which is associated with the secondary noncholinergic functions of the enzyme.This highlights the potential of this series for further optimization in the search of new coumarins for the treatment of Alzheimer's disease.
Referência(s)